Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BGLC

BioNexus Gene Lab (BGLC)

BioNexus Gene Lab Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BGLC
DateTimeSourceHeadlineSymbolCompany
05/31/20242:47PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
05/31/20242:46PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
05/31/20242:46PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
05/31/20242:45PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
05/31/20242:45PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BGLCBioNexus Gene Lab Corporation
05/09/202411:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
04/18/20241:52PMGlobeNewswire Inc.BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareNASDAQ:BGLCBioNexus Gene Lab Corporation
01/26/20243:05PMEdgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:BGLCBioNexus Gene Lab Corporation
01/23/20246:55AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BGLCBioNexus Gene Lab Corporation
11/03/20239:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
09/07/202310:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
07/24/20234:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGLCBioNexus Gene Lab Corporation
07/24/202310:30AMGlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
07/20/202312:29PMGlobeNewswire Inc.BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:BGLCBioNexus Gene Lab Corporation
 Showing the most relevant articles for your search:NASDAQ:BGLC